Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment

Introduction Telemedical lifestyle programmes for people with type 2 diabetes mellitus (T2DM) provide an opportunity to develop a healthier lifestyle and consequently to improve health outcomes. When implementing new programmes into standard care, considering patients’ preferences may increase the s...

Full description

Saved in:
Bibliographic Details
Main Authors: Veronika Gontscharuk, Andrea Icks, Michael Roden, Markus Vomhof, Sandra Grobosch, Jana Sommer, Jan Dyczmons
Format: Article
Language:English
Published: BMJ Publishing Group 2020-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/9/e036995.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556243110428672
author Veronika Gontscharuk
Andrea Icks
Michael Roden
Markus Vomhof
Sandra Grobosch
Jana Sommer
Jan Dyczmons
author_facet Veronika Gontscharuk
Andrea Icks
Michael Roden
Markus Vomhof
Sandra Grobosch
Jana Sommer
Jan Dyczmons
author_sort Veronika Gontscharuk
collection DOAJ
description Introduction Telemedical lifestyle programmes for people with type 2 diabetes mellitus (T2DM) provide an opportunity to develop a healthier lifestyle and consequently to improve health outcomes. When implementing new programmes into standard care, considering patients’ preferences may increase the success of the participants. This study aims to examine the preferences of people with T2DM with respect to telemedical lifestyle programmes, to analyse whether these preferences predict programme success and to explore the changes that may occur during a telemedical lifestyle intervention.Methods and analysis We outline the protocol of the development and assessment of a discrete choice experiment (DCE) to examine patient preferences in a telemedical lifestyle programme with regard to the functions of the online portal, communication, responsibilities, group activities and time requirements. To develop the design of the DCE, we conducted pilot work involving healthcare experts and in particular people with T2DM using cognitive pretesting. The final DCE is being implemented within a randomised controlled trial for investigating whether participation in a telemedical lifestyle intervention programme sustainably improves the HbA1c values in 850 members of a large German statutory health insurance with T2DM. Preferences are being assessed before and after participants complete the programme. The DCE data will be analysed using regression and latent class analyses.Ethics and dissemination The DCE study has been approved by the ethics committee of the medical faculty of the Heinrich Heine University Duesseldorf, registration number 2018-242-ProspDEuA, registered on 6 December 2018. The TeLIPro trial is registered at the US National Library of Medicine, registration number NCT03675919, registered on 15 September 2018. We aim to disseminate our results in peer-reviewed journals, at national and international conferences and among interested patient groups and the public.
format Article
id doaj-art-c53169f7208f49e8b1dd8365f9d7474a
institution Kabale University
issn 2044-6055
language English
publishDate 2020-09-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-c53169f7208f49e8b1dd8365f9d7474a2025-01-07T11:55:07ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2020-036995Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experimentVeronika Gontscharuk0Andrea Icks1Michael Roden2Markus Vomhof3Sandra Grobosch4Jana Sommer5Jan Dyczmons6Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, GermanyInstitute for Health Services Research and Health Economics, Centre for Health and Society (chs), Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Nordrhein-Westfalen, GermanyInstitute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University, Duesseldorf, GermanyGerman Center for Diabetes Research (DZD), Neuherberg, GermanyInstitute for Health Services Research and Health Economics, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University, Duesseldorf, GermanyInstitute for Health Services Research and Health Economics, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University, Duesseldorf, GermanyInstitute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, GermanyIntroduction Telemedical lifestyle programmes for people with type 2 diabetes mellitus (T2DM) provide an opportunity to develop a healthier lifestyle and consequently to improve health outcomes. When implementing new programmes into standard care, considering patients’ preferences may increase the success of the participants. This study aims to examine the preferences of people with T2DM with respect to telemedical lifestyle programmes, to analyse whether these preferences predict programme success and to explore the changes that may occur during a telemedical lifestyle intervention.Methods and analysis We outline the protocol of the development and assessment of a discrete choice experiment (DCE) to examine patient preferences in a telemedical lifestyle programme with regard to the functions of the online portal, communication, responsibilities, group activities and time requirements. To develop the design of the DCE, we conducted pilot work involving healthcare experts and in particular people with T2DM using cognitive pretesting. The final DCE is being implemented within a randomised controlled trial for investigating whether participation in a telemedical lifestyle intervention programme sustainably improves the HbA1c values in 850 members of a large German statutory health insurance with T2DM. Preferences are being assessed before and after participants complete the programme. The DCE data will be analysed using regression and latent class analyses.Ethics and dissemination The DCE study has been approved by the ethics committee of the medical faculty of the Heinrich Heine University Duesseldorf, registration number 2018-242-ProspDEuA, registered on 6 December 2018. The TeLIPro trial is registered at the US National Library of Medicine, registration number NCT03675919, registered on 15 September 2018. We aim to disseminate our results in peer-reviewed journals, at national and international conferences and among interested patient groups and the public.https://bmjopen.bmj.com/content/10/9/e036995.full
spellingShingle Veronika Gontscharuk
Andrea Icks
Michael Roden
Markus Vomhof
Sandra Grobosch
Jana Sommer
Jan Dyczmons
Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment
BMJ Open
title Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment
title_full Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment
title_fullStr Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment
title_full_unstemmed Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment
title_short Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment
title_sort preferences of people with type 2 diabetes for telemedical lifestyle programmes in germany protocol of a discrete choice experiment
url https://bmjopen.bmj.com/content/10/9/e036995.full
work_keys_str_mv AT veronikagontscharuk preferencesofpeoplewithtype2diabetesfortelemedicallifestyleprogrammesingermanyprotocolofadiscretechoiceexperiment
AT andreaicks preferencesofpeoplewithtype2diabetesfortelemedicallifestyleprogrammesingermanyprotocolofadiscretechoiceexperiment
AT michaelroden preferencesofpeoplewithtype2diabetesfortelemedicallifestyleprogrammesingermanyprotocolofadiscretechoiceexperiment
AT markusvomhof preferencesofpeoplewithtype2diabetesfortelemedicallifestyleprogrammesingermanyprotocolofadiscretechoiceexperiment
AT sandragrobosch preferencesofpeoplewithtype2diabetesfortelemedicallifestyleprogrammesingermanyprotocolofadiscretechoiceexperiment
AT janasommer preferencesofpeoplewithtype2diabetesfortelemedicallifestyleprogrammesingermanyprotocolofadiscretechoiceexperiment
AT jandyczmons preferencesofpeoplewithtype2diabetesfortelemedicallifestyleprogrammesingermanyprotocolofadiscretechoiceexperiment